Balchem Q1 2025 net sales rise 4.5% to $250.5 million; EPS $1.13 vs $0.89
Balchem reported first-quarter 2025 results for the period ended March 31, 2025, with net sales of $250.5 million, up 4.5%, and GAAP net earnings of $37.1 million, up 27.8%. Sales and earnings from operations grew in all three segments, and the company described the quarter's net sales and adjusted EBITDA as records.
Key points
- Net sales $250.5 million, up $10.9 million or 4.5% from the prior year quarter
- GAAP diluted EPS $1.13 vs $0.89; adjusted EPS $1.22 vs $1.03
- Adjusted EBITDA $66.3 million, up 8.9%; free cash flow $31.0 million
- Earnings call on April 24, 2025 at 11:00 AM ET; replay available through May 8, 2025
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:05 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 24, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.